FDA
-
-
-
-
-
-
-
Definium Therapeutics Announces First Patient Dosed in Ascend, the Second Phase 3 Pivotal Study of DT120 ODT in Major Depressive Disorder
-
-
-
-
-
-
-
Wolfe Research Starts Definium Therapeutics Inc (DFTX) at Outperform, Top Pick
-
-
-
-
323,981 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

